Swedish companies wanted to produce a Russian vaccine from Coronavirus “Satellite V”, reports the newspaper SVENSKA DAGBLADET newspaper.
So, the head of the Vinnova department Lars Hammarster noted that the company has the opportunity to produce the drug, but production will face some challenges. Among them are no capacity for large-scale grafting.
At the same time, the professor and expert on vaccines of the Caroline Institute Ali Mirazimi believes that all existing vaccines should be used in the world. According to him, if “satellite V” will be done in Europe, it will increase the transparency of production and the ability to control.